Several drug industry giants are now pledging to freeze price increases in the US, but some suggest the movement is a publicity stunt or worse
Amid significant pressure from President Trump, several of the world’s major pharmaceutical companies have promised not to raise the prices of their medicines in the US for the rest of the year. The White House is hailing the development as a major success for American consumers and health care, but many experts in the field describe it as a meaningless PR stunt.